Some features are unavailable

Your browser does not support JavaScript, or it is disabled.

ISSN Record 1521-0111

Identifiers

ISSN:: 1521-0111

ISSN-L:: 0026-895X

CODEN (1):: MOPMA3

Titles

Abbreviated key title:: Mol. pharmacol. (Online)

Title proper:: Molecular pharmacology.

Publication

Medium:: Online

Other media:: Print

Earliest publisher:: [Bethesda, Md.]: American Society for Pharmacology and Experimental Therapeutics

Latest publisher:: [New York]: Elsevier Inc.

Issuing body:: American Society for Pharmacology and Experimental Therapeutics.

Normalized publisher:: American Society for Pharmacology and Experimental Therapeutics [Wikidata: Q4745031]

Normalized publisher (brand):: [Wikidata: ]

Type:: Periodical

Frequency:: Monthly

Dates of publication:: 199?-

Status:: Published

Description:: Began in 1965.

Country:: UNITED STATES

Language:: English

Online

Subjects

Subject added entries:: Pharmacology. Therapeutics. Toxicology (615); Chemistry. Crystallography. Mineralogy (54)

Dewey Decimal Classification:: 615

Covered by

17 indexing sources

Cababstracts Crossref Ezb Fatcat Medline Openalex Pubmed Pubmedcentral Scopus Sherpa Romeo Sudoc Web Of Science Wikidata Zdb

Wikipedia (EN) Wikipedia (DE) Wikipedia (IT)

Search in

Archival status

This resource has been partly archived by the keepers network.

Archival Status
Publisher	Keeper		Status	Last updated	Access
on 1
Elsevier	Portico		Preserved	2026-02-12
Preserved : 2005: 67(1-6), 2005: 68(1-6), 2006: 69(1-6), 2006: 70(1-6), 2007: 71(1-6), 2007: 72(1-6), 2008: 73(1-6), 2008: 74(1-6), 2009: 75(1-6), 2009: 76(1-6), 2010: 77(1-6), 2010: 78(1-6), 2011: 79(1-6), 2011: 80(1-6), 2012: 81(1-6), 2012: 82(1-6), 2013: 83(1-6), 2013: 84(1-6), 2014: 85(1-6), 2014: 86(1-6), 2015: 87(1-6), 2015: 88(1-6), 2016: 89(1-6), 2016: 90(1-6), 2017: 91(1-6), 2017: 92(1-6), 2018: 93(1-6), 2018: 94(1-6), 2019: 95(1-6), 2019: 96(1-6), 2020: 97(1-6), 2020: 98(1-6), 2021: 99(1-6), 2021: 100(1-6), 2022: 101(1-6), 2022: 102(1-6), 2023: 103(1-6), 2023: 104(1-6), 2024: 105(1-6), 2024: 106(1), 2025: 107(1-12), 2026: 108(1)
Elsevier	Scholars Portal		Preserved	2025-09-02
Preserved : 65 (1 to 3); 80 (, 2 to 6); 81 (, 1, 4 to 6); 82 (, 1); 83 (, 1 to 6); 84 (, 1, 2, 4 to 6); 85 (, 3, 4); 86 (, 1 to 5); 87 (, 1, 5, 6); 88 (, 1 to 3); 89 (, 1 to 6); 90 (, 1 to 6); 91 (, 1 to 6); 92 (, 1 to 6); 93 (, 1 to 6); 94 (, 1 to 6); 95 (, 1 to 6); 96 (, 1 to 6); 97 (, 1 to 6); 98 (, 1 to 6); 99 (, 1 to 6); 100 (, 1, 3 to 6); 101 (, 1 to 6); 102 (, 1 to 6); 103 (, 1 to 6); 104 (, 1 to 6); 105 (, 1 to 6); 106 (, 1, 2); 107 (, 1 to 8); 2004; 2011; 2012; 2013; 2014; 2015; 2016; 2017; 2018; 2019; 2020; 2021; 2022; 2023; 2024; 2025
Elsevier	CLOCKSS Archive		Preserved	2026-02-09
107
American Society for Pharmacology and Experimental Therapeutics	CLOCKSS Archive		Preserved	2026-02-09
1 to 94
American Society for Pharmacology and Experimental Therapeutics	LOCKSS Archive		Preserved	2026-02-09
1 to 104
American Society for Pharmacology and Experimental Therapeutics	CLOCKSS Archive		In Progress	2026-02-09
95 to 105

Record

Last modified:: 2025/01/09

ISSN Center responsible for the record:: Netherlands

Notes

1:: Mode of access: World Wide Web.

2:: Description based on: 54 (2) (Aug. 98) (viewed Aug. 7, 1998); title from table of contents screen.

3:: Latest issue consulted: Vol. 56, no. 2 (Aug. 1999).